Zhi Peng
机构：Peking University, Peking University Cancer Hospital
发表论文 2 篇 · 总被引 3 次 · h-index 1
代表论文
- Immunosuppressive immune microenvironment landscapes in VISTA-high gastric cancer (2026 · British Journal of Cancer · 被引 3)
- Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial (2026 · British Journal of Cancer)